Cargando…

Prediction of IDH Status Through MRI Features and Enlightened Reflection on the Delineation of Target Volume in Low-Grade Gliomas

Isocitrate dehydrogenase mutational status defines distinct biologic behavior and clinical outcomes in low-grade gliomas. We sought to determine magnetic resonance imaging characteristics associated with isocitrate dehydrogenase mutational status to evaluate the predictive roles of magnetic resonanc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Haixia, Huang, Yong, Li, Zhiqiang, Li, Sirui, Chen, Qiongrong, Xie, Conghua, Zhong, Yahua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767744/ https://www.ncbi.nlm.nih.gov/pubmed/31564237 http://dx.doi.org/10.1177/1533033819877167

Ejemplares similares

A new approach to delineating clinical target volume for radiotherapy of glioblastoma: A phase II trial
por: Huang, Yong, et al.
Publicado: (2022)

Neutrophil–lymphocyte ratio dynamics are useful for distinguishing between recurrence and pseudoprogression in high-grade gliomas
por: Huang, Yong, et al.
Publicado: (2019)

Optimization of supraclavicular lymph node clinical target volume delineation in high-risk breast cancer: a single center experience and recommendation
por: Li, Li, et al.
Publicado: (2023)

Optimization of cervical lymph node clinical target volume delineation in nasopharyngeal carcinoma: a single center experience and recommendation
por: Li, Li, et al.
Publicado: (2018)

Preoperative and Noninvasive Prediction of Gliomas Histopathological Grades and IDH Molecular Types Using Multiple MRI Characteristics
por: Du, Ningfang, et al.
Publicado: (2022)

Impact of Postoperative Changes in Brain Anatomy on Target Volume Delineation for High-Grade Glioma
por: Dejonckheere, Cas Stefaan, et al.
Publicado: (2023)

IDH mutation-specific radiomic signature in lower-grade gliomas
por: Liu, Xing, et al.
Publicado: (2019)

Pharmacoresistant seizures and IDH mutation in low-grade gliomas
por: Correia, Carlos Eduardo, et al.
Publicado: (2021)

Seizures in patients with IDH-mutated lower grade gliomas
por: Carstam, Louise, et al.
Publicado: (2022)

Delineation of Grade II and III Gliomas Investigated by 7T MRI: An Inter-Observer Pilot Study
por: Prener, Martin, et al.
Publicado: (2023)

IDH mutations but not TERTp mutations are associated with seizures in lower-grade gliomas
por: Duan, Wen-chao, et al.
Publicado: (2018)

PREOPERATIVE DETERMINATION OF IDH STATUS AND GRADE IN GLIOMAS USING MRS
por: Nguyen, Thanh Binh
Publicado: (2023)

Matching Quantitative MRI Parameters with Histological Features of Treatment-Naïve IDH Wild-Type Glioma
por: Maurer, Gabriele D., et al.
Publicado: (2021)

Is intracranial volume a risk factor for IDH-mutant low-grade glioma? A case–control study
por: Sagberg, Lisa Millgård, et al.
Publicado: (2022)

Transcriptional Characteristics of IDH-Wild Type Glioma Subgroups Highlight the Biological Processes Underlying Heterogeneity of IDH-Wild Type WHO Grade IV Gliomas
por: Chang, Yu-Zhou, et al.
Publicado: (2020)

Ultra-high-field sodium MRI as biomarker for tumor extent, grade and IDH mutation status in glioma patients
por: Regnery, Sebastian, et al.
Publicado: (2020)

Diffusion tensor image features predict IDH genotype in newly diagnosed WHO grade II/III gliomas
por: Eichinger, Paul, et al.
Publicado: (2017)

Preoperative imaging features: Are they useful tools for predicting IDH1 mutation status in gliomas Grades II–IV?
por: Merenzon, Martin Andres, et al.
Publicado: (2022)

High-dose radiation associated with improved survival in IDH-wildtype low-grade glioma
por: Liu, Shuai, et al.
Publicado: (2021)

Qualitative and Quantitative MRI Analysis in IDH1 Genotype Prediction of Lower-Grade Gliomas: A Machine Learning Approach
por: Cao, Mengqiu, et al.
Publicado: (2021)

Computational Analysis of IDH1, IDH2, and TP53 Mutations in Low-Grade Gliomas Including Oligodendrogliomas and Astrocytomas
por: Bendahou, Mohammed Amine, et al.
Publicado: (2020)

Multicenter DSC–MRI-Based Radiomics Predict IDH Mutation in Gliomas
por: Manikis, Georgios C., et al.
Publicado: (2021)

The MRI Features and Prognosis of Gliomas Associated With IDH1 Mutation: A Single Center Study in Southwest China
por: Shen, Guiquan, et al.
Publicado: (2020)

Noninvasive Determination of the IDH Status of Gliomas Using MRI and MRI-Based Radiomics: Impact on Diagnosis and Prognosis
por: Li, Yurong, et al.
Publicado: (2022)

Comparison of T2 and FLAIR imaging for target delineation in high grade gliomas
por: Stall, Bronwyn, et al.
Publicado: (2010)

Transcriptomic Analysis of Glioma Based on IDH Status Identifies ACAA2 as a Prognostic Factor in Lower Grade Glioma
por: Wu, Chenxing, et al.
Publicado: (2020)

Predicting IDH Mutation Status in Low-Grade Gliomas Based on Optimal Radiomic Features Combined with Multi-Sequence Magnetic Resonance Imaging
por: He, Ailing, et al.
Publicado: (2022)

Pre-surgical connectome features predict IDH status in diffuse gliomas
por: Kesler, Shelli R., et al.
Publicado: (2019)

Therapies for IDH-Mutant Gliomas
por: Alshiekh Nasany, Ruham, et al.
Publicado: (2023)

The Value of Enhanced MR Radiomics in Estimating the IDH1 Genotype in High-Grade Gliomas
por: Niu, Lei, et al.
Publicado: (2020)

MR-detectable metabolic biomarkers of response to mutant IDH inhibition in low-grade glioma
por: Molloy, Abigail R, et al.
Publicado: (2020)

ACT-5 Prognosis of IDH-mut lower-grade gliomas in Hokkaido University Hospital
por: Yamaguchi, Shigeru, et al.
Publicado: (2021)

Genetic Alteration Analysis of IDH1, IDH2, CDKN2A, MYB and MYBL1 in Pediatric Low-Grade Gliomas
por: Barinfeld, Orit, et al.
Publicado: (2022)

CTV Delineation for High-Grade Gliomas: Is There Agreement With Tumor Cell Invasion Models?
por: Häger, Wille, et al.
Publicado: (2022)

Correlating MRI features with additional genetic markers and patient survival in histological grade 2-3 IDH-mutant astrocytomas
por: Lasocki, Arian, et al.
Publicado: (2023)

The Utility of Diffusion and Perfusion Magnetic Resonance Imaging in Target Delineation of High-Grade Gliomas
por: Fei, Qian, et al.
Publicado: (2020)

DZIP3 is a key factor to stratify IDH1 wild-type lower-grade gliomas
por: Liang, Tingyu, et al.
Publicado: (2020)

Establishment of a Prediction Model Based on Preoperative MRI Radiomics for Diffuse Astrocytic Glioma, IDH-Wildtype, with Molecular Features of Glioblastoma
por: Du, Peng, et al.
Publicado: (2023)

The comparison of clinical and biological characteristics between IDH1 and IDH2 mutations in gliomas
por: Wang, Hao-Yuan, et al.
Publicado: (2016)

Early volumetric, perfusion, and diffusion MRI changes after mutant isocitrate dehydrogenase (IDH) inhibitor treatment in IDH1-mutant gliomas
por: Cho, Nicholas S, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6nummoiv4232g68nu50v84dbl8